Показатели клеточного и гуморального иммунитета у больных лейомиомой матки в репродуктивном возрасте

Abstract

Objective: to determine changes in clinical and immunological parameters in patients with uterine leiomyoma, depending on the reproductive age. Study design: cohort prospective comparative study. Materials and methods. Investigation and surgical treatment of 220 patients of reproductive age was conducted. The main group consisted of 190 women aged 18-45 years, including 110 patients of early age (18-35 years) and 80 women of late reproductive age (36-45 years). Criteria for inclusion in the main group were uterine leiomyoma and the woman's reproductive age. The control group included 30 healthy women aged 18-45 years with normal reproductive function and no gynecological diseases. Results. Immunological parameters of peripheral blood of women with uterine leiomyoma were characterized by a statistically significant increase in comparison with the control group. The maximum and reliable values of the growth in the number of lymphocytes, the absolute content of CD3 +, CD8 +, CD19 + and CD16 + / 56 + lymphocytes, the NST test, complementary activity and circulating immune complexes of serum were determined in women of early reproductive age (p<0,05-0,001). Quantitative values of these parameters in patients of late age had an intermediate character and significantly lower values than at an early age, but did not reach the level of the control group. inclusion. Leiomyoma in reproductive age was accompanied by intensity of cellular and humoral immunity. The immune response in patients with uterine leiomyoma was differentiated depending on the period of reproductive age and was more pronounced in patients 18-35 years of age.